10mg Kisspeptin Vial
10mg Kisspeptin Vial
50mg GHK-cu Vial GHK-Cu 50mg Vial – Copper Peptide
5mg DSIP Vial DSIP Peptide (Delta-Sleep-Inducing Peptide) 5mg Vial

Kisspeptin-10 (KP-10) 10mg Vial

0 out of 5

Original price was: $59.99.Current price is: $54.99.

Enhanced Sexual Desire and Arousal

  • Human studies show kisspeptin activates brain areas linked to sexual arousal and attraction (such as the amygdala and hypothalamus).

  • It may increase sexual motivation and emotional connection, particularly in individuals with low libido.

    Improved Erectile Function (Indirect)

    • Kisspeptin increases testosterone levels through stimulation of GnRH → LH → testosterone pathway.

    • Healthy testosterone levels support libido, erection quality, and sexual performance.

    • It may also enhance vascular and nitric oxide signaling, though data are limited.

      Mood and Emotional Bonding

      • Kisspeptin modulates limbic and cortical brain regions linked to attraction, empathy, and emotional intimacy.

      • This suggests potential benefits for couples with emotional or sexual disconnection.

        Fertility Support

        • In both sexes, kisspeptin helps restore normal reproductive hormone signaling.

        • In women, it can induce ovulation and normalize menstrual cycles.

        • In men, it boosts sperm production and testosterone via LH and FSH stimulation.

        • Clinical trials have explored kisspeptin as a safer alternative to hCG in IVF and hypogonadism.

Categories: , , , , , , , Tags: , , ,
10mg Kisspeptin Vial

Kisspeptin-10 (KP-10) 10mg Vial

Original price was: $59.99.Current price is: $54.99.

In stock
Add to wishlist

Description

✅ Sexual / Reproductive Benefits

Here are the sex-/libido-related benefits supported by human/animal studies:

  • In men with hypoactive sexual desire disorder (HSDD), administration of kisspeptin-54 (1 nmol/kg/h IV infusion for 75 minutes) produced significant increases in penile tumescence (erection measure) when viewing erotic stimuli — up to ~56% more than placebo.

  • In women with HSDD, a similar infusion protocol of kisspeptin-54 led to brain-imaging changes in sexual/attraction brain networks.

  • Kisspeptin stimulates the hypothalamic-pituitary-gonadal axis (HPG axis) — it triggers release of gonadotropin-releasing hormone (GnRH), which then boosts LH/FSH, and downstream sex-hormones (testosterone, estrogen) in many contexts.

  • Because of the hormone effect, it’s been studied for fertility, sexual desire, and hormonal deficiency contexts (e.g., low libido, hypogonadism) in men and women.

So in short: the main sexual benefits are increased sexual desire / arousal, improved erectile response in men, and potential improvement in female sexual response/attraction networks.

🎯 Dosage & Administration

Here are reported dosage/administration details from studies and protocols. Note that there is no “standard approved” clinical dosage for libido.

• Human clinical infusion studies

  • One key study: men received an infusion of kisspeptin-54 at 1 nmol/kg/h IV for 75 minutes vs placebo.

  • In women: the same infusion rate (1 nmol/kg/h) over 75 minutes was used.

  • These protocols use IV rather than typical subcutaneous injection and are in research settings.

• More “protocol” sources (non-approved)

  • Some dosing guides list for “libido/sexual enhancement”: ~50 mcg every 2-3 days (subcutaneous) for kisspeptin.

  • Others show for “hypogonadism/testosterone support”: ~100-300 mcg per injection, 3-5 times per week (SC).

  • Some sources propose for sexual enhancement: 100-200 mcg per injection “as needed (1-2 hours before activity)” in SC form.

• Summary table

Route Dose example Frequency Note
IV infusion (research) ~1 nmol/kg/h (~many µg/kg) Single 75-min session Men & women HSDD study
SC injection (protocol) ~50-200 mcg Every 2-3 days or “as needed” Off-label, non-approved use
SC injection (hormone support) ~100-300 mcg 3-5× per week For hypogonadism/fertility context

⚠️ Safety, Limitations & Precautions

  • Kisspeptin is not currently approved for treatment of sexual dysfunction or libido. Studies are limited and mostly in controlled research settings.

  • Long-term safety data are very limited. Some dosing guides caution about receptor desensitization with too frequent dosing.

  • Because it affects the HPG axis, there is potential for altering hormone balance (LH, FSH, testosterone/estrogen). Monitoring would be essential.

  • Side effects reported in studies were minimal, but: injection-site reactions, flushing, hormone over-stimulation or imbalance are possible.

  • Some sources caution about “research use only” status. For example: “Kisspeptin-10 is primarily research compound with limited human clinical data …”

  • Because of the hormone effects, use in pregnancy, breastfeeding, hormone-sensitive cancers, or without medical supervision would carry significant risk.